课题基金 / 基金详情

Molecular mechanism of natural pluripotency establishment in the early mouse embryo based on single-cell gene expression profile

Molecular mechanism of natural pluripotency establishment in the early mouse embryo based on single-cell gene expression profile
基于单细胞基因表达谱的小鼠早期胚胎自然多能性建立的分子机制
批准号:
66168481
负责人:
Dr. Takashi Hiiragi
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2008
资助国家:
德国
项目状态:
已结题
起止时间:
2007-12-31 至 2014-12-31

项目摘要

项目成果

Dr. Takashi Hiiragi的其他基金

相似基金

相关文献

中文摘要
翻译
了解导致体内自然多能性建立的分子机制对于干细胞生物学在再生医学中的有效应用至关重要。本项目的主要目的是了解小鼠囊胚多能性内细胞团形成的分子程序,这也将阐明胚胎干细胞的分子特性。本项目旨在将单细胞基因表达谱应用于小鼠着床前胚胎,以全面表征导致多能谱系分离的分子特征。在过去的两年中,我们成功地建立了内细胞群细胞的方法和分子特征。这导致我们i)鉴定了内细胞群中两个不同群体的分子特征,外胚层和原始内胚层;Ii)识别最早可能的标记,从而确定谱系分离的潜在关键因素;Iii)表征在早期发育阶段突出的随机基因表达。在这个提议中,我们将采用同样的成功策略来表征内细胞群和滋养外胚层细胞系之间的分离,这种分离可能发生在早期发育阶段,桑葚胚。总之,这将允许全面表征关键分子和导致体内基态初始多能性形成的潜在机制。
英文摘要
Understanding of the molecular mechanism leading to establishment of natural pluripotency in vivo is crucial for the efficient application of stem cell biology to regenerative medicine. The principal aim of this project is to understand the molecular program underlying formation of the pluripotent inner cell mass in the mouse blastocyst, which will also elucidate molecular properties of embryonic stem cells. This project focuses on applying single-cell gene expression profiling to the mouse pre-implantation embryo, in order to comprehensively characterize molecular signature leading to the pluripotent lineage segregation. In the last two years, we have successfully established the methodologies and characterized molecular signatures within the inner cell mass cells. This led us to i) identify the molecular signature characteristic to two distinct populations in the inner cell mass, epiblast and primitive endoderm; ii) identify the earliest possible markers, thus potential key players, for the lineage segregation; iii) characterize stochastic gene expression prominent in the early developmental stages. In this proposal, we will apply the same successful strategy to characterize the segregation between the inner cell mass and trophectoderm cell lineages, likely taking place in the earlier developmental stage, morula. Altogether this will allow comprehensive characterization of key molecules and the underlying mechanism leading to the formation of ground state naive pluripotency in vivo.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1159/000118783
发表时间: 2008-01-01
期刊: CELLS TISSUES ORGANS
影响因子: 2.7
作者: [Dietrich, Jens Erik, Hiiragi, Takashi]
通讯作者: Hiiragi, Takashi
DOI: 10.1242/dev.014555
发表时间: 2008-04-15
期刊: DEVELOPMENT
影响因子: 4.6
作者: [Honda, Hisao, Motosugi, Nami, Hiiragi, Takashi]
通讯作者: Hiiragi, Takashi
DOI: 10.1007/978-3-642-30406-4_6
发表时间: 2012-01-01
期刊: Results and problems in cell differentiation
影响因子: --
作者: [Courtois, Aurelien, Hiiragi, Takashi]
通讯作者: Hiiragi, Takashi
DOI: 10.1002/dvg.20377
发表时间: 2008-03-01
期刊: GENESIS
影响因子: 1.5
作者: [Bauer, Tobias, Motosugi, Nami, Hiiragi, Takashi]
通讯作者: Hiiragi, Takashi
Molecular characterisation of the establishment of and exit from pluripotency in the mouse embryo by combining live-imaging and single-cell RNA-seq
  • 批准号:
    266274777
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Dr. Takashi Hiiragi
  • 依托单位:
Understanding molecular mechanism and biological siginificance of dynamic fluctuation and heterogeneity of gene expression in ES cells and in the early mouse embryo
  • 批准号:
    158972463
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2009
  • 负责人:
    Dr. Takashi Hiiragi
  • 依托单位:
Identification of the most reprogramming-potent oocyte for more efficient cloning and for a long-term approach to the isolation of reprogramming factor(s)
国内基金
海外基金
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
  • 批准号:
    82371651
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵栋
  • 依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
  • 批准号:
    82370798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王晓
  • 依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
  • 批准号:
    82371332
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    胡琴
  • 依托单位: